MedTrace Logo

p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management

NCT02522585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-04-20

No results posted yet for this study

Summary

The objective of this study is to evaluate the outcome of cervical intraepithelial neoplasia grade 2 (CIN-II) patients followed up without treatment for 24 months according to p16 and ki-67 immunohistochemical staining and to the expression of NK cell receptors.

Conditions

Interventions

OTHER

Conservative management

Control of CIN-II with cytology and colposcopy to try to avoid unnecessary surgery

Sponsors & Collaborators

  • Parc de Salut Mar

    lead OTHER

Principal Investigators

  • Gemma Mancebo, PhD · Parc de Salut Mar

  • Ramon Carreras, PhD · Parc de Salut Mar

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2015-11-30
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02522585 on ClinicalTrials.gov